Seelos Therapeutics Inc. (SEEL) recent quarterly performance of -38.48% is not showing the real picture


Seelos Therapeutics Inc. (NASDAQ: SEEL) started the day on November 23, 2022, with a price increase of 5.66% at $0.81. During the day, the stock rose to $0.85 and sunk to $0.7681 before settling in for the price of $0.77 at the close. Taking a more long-term approach, SEEL posted a 52-week range of $0.48-$2.12.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


Meanwhile, its Annual Earning per share during the time was 54.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -70.30%. This publicly-traded company’s shares outstanding now amounts to $106.69 million, simultaneously with a float of $103.97 million. The organization now has a market capitalization sitting at $90.06 million. At the time of writing, stock’s 50-day Moving Average stood at $0.9552, while the 200-day Moving Average is $0.8888.

Seelos Therapeutics Inc. (SEEL) Ownership Facts and Figures

Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Seelos Therapeutics Inc.’s current insider ownership accounts for 0.10%, in contrast to 29.20% institutional ownership. According to the most recent insider trade that took place on Jun 01, this organization’s Director bought 16,000 shares at the rate of 0.61, making the entire transaction reach 9,789 in total value, affecting insider ownership by 16,000. Preceding that transaction, on Mar 31, Company’s official bought 66,667 for 0.85, making the whole transaction’s value amount to 56,840. This particular insider is now the holder of 3,281,546 in total.

Seelos Therapeutics Inc. (SEEL) Earnings and Revenue Records

In the latest quarterly report released, which was put into the public domain on 6/29/2022, the organization reported -$0.2 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.14) by -$0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.

Seelos Therapeutics Inc.’s EPS decrease for this current 12-month fiscal period is -70.30% and is forecasted to reach -0.57 in the upcoming year.

Seelos Therapeutics Inc. (NASDAQ: SEEL) Trading Performance Indicators

Let’s observe the current performance indicators for Seelos Therapeutics Inc. (SEEL). It’s Quick Ratio in the last reported quarter now stands at 1.90. The Stock has managed to achieve an average true range (ATR) of 0.07.

In the same vein, SEEL’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.78, a figure that is expected to reach -0.14 in the next quarter, and analysts are predicting that it will be -0.57 at the market close of one year from today.

Technical Analysis of Seelos Therapeutics Inc. (SEEL)

If we take a close look at the recent performances of Seelos Therapeutics Inc. (NASDAQ: SEEL), its last 5-days Average volume was 0.42 million that shows plunge from its year to date volume of 1.3 million. During the previous 9 days, stock’s Stochastic %D was recorded 11.74% While, its Average True Range was 0.0698.


Please enter your comment!
Please enter your name here